Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Excellent outcome after late retransplantation of the liver during the last decade

W Polak, P Peeters, K de Jong, M de Boer, A van den Berg, H Verkade, R Scheenstra, E Haagsma, H Hendriks, M Slooff, R Porte

Ann Transplant 2009; 14(1): 29-29 :: ID: 880302

Abstract

The need for late re-transplantation (RTx) grows in parallel with better  long-term survival after liver transplantation. RTx is the only solution for late graft failure, but it has been associated with inferior outcome compared to the primary transplantation. In contrast to early RTx for primary graft non- or dysfunction, late RTx is traditionally considered a challenging procedure because of massive perihepatic adhesions, recurrent portal hypertension, and effects of a long-term immunosuppressive treatment. The present study analyzes the results of late RTx at our institution during the last decade. Outcome parameters were patient's and graft's survival, morbidity, and operative parameters. Between January 1995 and June 2008, 56 patients underwent late RTx (>1 year after the first transplant). The main cause of late RTx was non-anastomotic biliary strictures (32%). The median time between the initial transplant and late RTx was 5.9 years (range 1.1-18.2 years). Overall 1-, 3- and 5-years patient's survival after RTx was 86%, 84%, and 78%, respectively. Overall graft's survival at the same time points was 70%, 66% and 60%, respectively. Median blood loss during RTx was 5.4 l (0.4-65.0) and median RBC transfusion was 6.5 units (0-44). Five patients (9%) did not require any RBC transfusion. Postoperative complications occurred in 75% of the patients and among them infectious complications were the most common (39%). In univariate analyses, the following variables were significantly associated with mortality after RTx: the need for a second or third RTx, pre-transplant Child-Pugh score, surgical technique (conventional technique versus piggy back), post-transplant ICU stay, intubation time, septic complications, and the need for reinterventions. However, after multivariate Cox regression analysis only septic complications remained as a significant independent predictor of patient survival. In conclusion, excellent short- and long-term survival can be obtained after late RTX of the liver. Postoperative sepsis is the main risk factor for poor outcome, indicating that adequate antimicrobial prophylaxis and microbiological surveillance are of great importance after late RTx.

Keywords: Liver Transplantation, clinical outcome

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358